Resources
Cancer Plan: Evaluation
Evaluation is a critical and central component of Maine’s comprehensive cancer control initiatives. It is through the evaluation process that activities can be monitored, Consortium membership satisfaction can be assessed, and progress towards reducing the burden of cancer in Maine can be established. The evaluation of the Maine Cancer Plan and the Consortium is based on the Centers for Disease Control and Prevention’s evaluation framework. The figure below depicts the essential components of this framework.
Figure 31: Framework for Program Evaluation in Public Health
Three areas have been identified as the focus for the evaluation design. They include context, implementation, and outcomes (Figure 32). Experts agree that if used together, these three components can improve the program’s effectiveness and promote future sustainability.
Figure 32. Comprehensive Cancer Control Evaluation Desin
Source: Maine Comprehensive Cancer Control Evaluation Report 2005.
Goal: Enhance the Maine Comprehensive Cancer Control initiative through evaluation.
Objective 1: Develop a five-year written evaluation plan to annually assess the partnership and measure progress related to the Maine Cancer Plan (2006-2010) by June 30, 2007.
Strategies
- The Maine Cancer Consortium in conjunction with the Maine Comprehensive Cancer Control Program will identify an evaluation team to spearhead the development of the evaluation plan.
- Members of the Maine Cancer Consortium will participate in three planning meetings regarding the development of the evaluation plan.
- The Maine Cancer Consortium will review the evaluation plan and provide recommendations for modifying the plan, if needed.
Objective 2: The Maine Cancer Consortium, in conjunction with the lead agency and evaluation team, will participate in the implementation of the evaluation plan (as specified in the plan) through December 31, 2011.
Strategies
- Fifty percent of Maine Cancer Consortium individual and organizational members will complete an annual partnership survey.
- The Maine Cancer Consortium will annually document progress related to the strategies in the Cancer Plan using tools developed by the evaluation team.
Objective 3: The lead agency and evaluation team will develop and disseminate the annual evaluation report beginning June 30, 2007.
Strategies
- Members of the Maine Cancer Consortium will review the draft annual report and provide feedback to the evaluation team.
- The lead agency and the evaluation team will disseminate the annual evaluation report.
« Back to Cancer Plan